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Abstract 
Cancer-related fatigue (CRF) is a persistent and debilitating problem for many breast 
cancer survivors. Although many CRF measurement tools are available, no consensus 
exists on the most appropriate tool to use for breast cancer survivors. The purpose of this 
project was to identify the best method of assessing CRF in breast cancer survivors. The 
practice-focused question inquired about the most appropriate way to assess fatigue in 
breast cancer survivors. The central concepts of the project were CRF and cancer 
survivorship. This project was informed by the theory of health as expanding 
consciousness and Mishel’s theory of uncertainty in illness. The sources of evidence 
included multi-database searches and literature from professional organizations. Results 
were tracked using preferred reporting items for systematic reviews and metasystems and 
a literature review matrix. The search identified 14 sources, which were assessed for 
quality using the grading of recommendations, assessment, development, and evaluation 
process. The results of this systematic review did not support the use of any particular 
assessment tool; however, 2 clinical practice guidelines recommended screening using a 
numerical severity scale followed by detailed assessment of clinically significant fatigue 
using available assessment tools. Screening can be implemented into the survivorship 
clinic, allowing nurses to identify potentially clinically significant fatigue so that further 
workup is done and interventions are implemented. Identifying, assessing, and 
intervening for clinically significant fatigue can improve the quality of life for breast 
cancer survivors, contributing to positive social change.  
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Section 1: Nature of the Project 
Introduction 
With advances in treatment, the survival rate for breast cancer is increasing, 
creating a large population with unique needs based on what they have been through in 
their cancer treatment (Appling, Scarvalone, MacDonald, McBeth, & Helzlsouer, 2012). 
Fatigue is one of the most commonly reported symptoms after breast cancer treatment, 
negatively affecting the recovery of an estimated 40% of survivors for as long as 10 years 
(Appling et al., 2012). 
Fatigue itself is a complex concept. It is highly subjective and relies on patient 
report of symptoms. Many factors contribute to its severity (e.g., pain, sleep disturbances, 
depression, anxiety, decreased physical activity, cognitive problems, weight gain, and 
menopausal symptoms). Fatigue can negatively affect quality of life (QOL) and can be 
frustrating for patients and providers (Appling et al., 2012). Although many models and 
scales are available to measure cancer-related fatigue (CRF) for patients undergoing 
active treatment, a lack of consensus exists on an appropriate method to assess this in 
breast cancer survivors (Noonan, 2016). 
To provide care effectively to breast cancer survivors, nurses need to be able to 
perform an evidence-based assessment of fatigue. This project was a systematic review of 
the literature in which I provide guidance on the most appropriate method to assess this 
complex and persistent symptom. Being able to assess the fatigue adequately is the first 
step in developing interventions for the problem. Addressing this prominent problem 
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should improve the QOL of breast cancer survivors and contribute to positive social 
change. 
Problem Statement 
Breast cancer is common among American women; 1 in 8 will develop invasive 
breast cancer. As of January 2018, an estimated 3.1 million women were living with a 
history of breast cancer, and researchers anticipate 266,120 new cases of invasive breast 
cancer diagnosed in 2019 (Breastcancer.org, n.d.). Due to increased awareness and early 
screening, women are being diagnosed earlier in the disease. Therefore, the mortality due 
to breast cancer has been decreasing through the years (Breastcancer.org, n.d.). Similar to 
the general trend for the United States, in Arkansas, breast cancer mortality has decreased 
steadily in recent years. Regardless of stage at diagnosis, the overall survival rate at 5 
years is 77% and at 10 years is 62% (Arkansas Department of Health, 2017). 
In a review of CRF by Weis (2011), fatigue was one of the most frequent 
symptoms occurring during treatment with prevalence rates ranging from 59 to 100%. 
The level of fatigue was higher among long-term survivors than in the general population 
and persisted more often with long-term and late effects. CRF negatively affected QOL 
by interfering with work life, family life, and sexuality (Weis, 2011). CRF correlates with 
sleep disorders (Ryan et al., 2007), and a relationship exists between depression, anxiety, 
psychological distress, and CRF (Fabi et al., 2017). CRF has negative consequences for 
the patient, the spouse and family, and the health economy as a whole. Cancer patients 
suffering from CRF, compared with patients without CRF, sought more health services, 
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had higher rates of sick leave, and had more loss of work capacity, with some sufferers 
not returning to work (Weis, 2011). 
My focus in this project was on the prevalence of CRF interfering with QOL in 
breast cancer survivors at Arkansas’s cancer center. There is an ever-increasing number 
of breast cancer survivors, and many contend with CRF (Fabi et al., 2017). Therefore, it 
is important to have an evidence-based fatigue assessment. The diagnosis of breast cancer 
is life changing; the treatment is tedious and damaging, and it can leave a person altered 
and physically and emotionally drained. Nurses and health care providers need to address 
how best to help patients overcome the challenges of CRF so that they can experience 
improved QOL in long-term survivorship (Appling et al., 2012). 
The local relevance of the need to address CRF is supported by the Arkansas 
Cancer Coalition’s (ACC) report, issued in 2015, outlining the state plan to address 
cancer. Among the topics of concern in that report is survivorship care. One objective of 
the state plan is to “educate health care providers on their role in survivorship by 
addressing cancer survivor’s needs and care-related issues to improve survivorship care” 
(ACC, 2015, p. 47). Another objective is to “address the needs of cancer survivors and 
their families to improve survivorship care” (ACC, 2015, p. 48). The findings of this 
project may be used by health care providers to address the needs of cancer survivors and 
educate health care providers on the specific psychosocial needs of this patient 
population. 
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Purpose Statement 
The gap in practice that I addressed in this project is a lack of consensus on a 
consistent method of assessing CRF in breast cancer survivors (see Noonan, 2016). My 
purpose in this project was to identify the best method of assessing CRF in breast cancer 
survivors and develop a plan for dissemination of the findings and implementation in the 
survivor clinic. The practice-focused question was the following: What is the most 
appropriate way to assess fatigue in breast cancer survivors? 
This project has the potential to address the gap in practice. Through my findings, 
I have identified an appropriate method for assessing CRF in breast cancer survivors. 
This assessment method can then be used by health care providers in clinical practice to 
improve care of breast cancer survivors by addressing the prevalent and life-altering 
struggle that is CRF. Beyond the scope of this project, the results of this project could aid 
in further study of interventions in the treatment of CRF. 
Nature of the Doctoral Project 
The nature of the project is a systematic review of the evidence. Researchers use 
this type of project to create an unbiased, comprehensive summary of the research on a 
particular topic (Walden University, 2017b). Specifically, this project was a systematic 
review of the literature on the assessment of CRF in breast cancer survivors. 
Sources of Evidence 
Sources of evidence included textbooks on cancer survivorship and oncology 
symptom management. These sources established an understanding of what is known 
about CRF assessment. I then conducted a multidatabase search through Thoreau and the 
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Walden Library website. Key search terms included CRF and breast cancer survivors. 
Inclusion criteria included current (published in 2012 or later), peer-reviewed, scholarly 
journals, and professional organizations that specialize in cancer and survivorship. This 
included the practice standards and guidelines from organizations such as Oncology 
Nursing Society (ONS), American Society of Clinical Oncology (ASCO), National 
Comprehensive Cancer Network (NCCN), and Advanced Practice Society for 
Hematology and Oncology (APSHO). 
Approach 
The approach was the structured literature review organized around the central 
concept of assessment of CRF. I critically appraised each article or source for its 
significance, applicability, clarity in presentation of findings, and quality of research 
conducted (see Terry, 2015) and used the GRADE process to classify the quality of the 
evidence. This system is widely used by organizations such as the World Health 
Organization and the Cochrane Review. The process is explicit and rigorous yet user 
friendly, allowing for simplicity and transparency. Each piece of evidence is classified 
into one of four levels: high, moderate, low, and very low (Guyatt et al., 2008). 
Significance 
Stakeholders 
Key stakeholders in this practice problem include the patients and health care 
providers for breast cancer survivors. The patients will benefit from interventions 
directed at managing CRF. The clinical providers will benefit from having clarity on 
which evidence-based tool may be appropriate and useful. 
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Contribution to Nursing Practice 
Evidence suggests that CRF is important to nursing practice. For example, the 
Holden Comprehensive Cancer Center at the University of Iowa attempted education and 
interventions to address CRF in 1995. Unfortunately, CRF is thought of as an untreatable 
and inevitable consequence and is inconsistently addressed and inadequately managed. 
Newer efforts (Huether, Abbott, Cullen, Cullen, & Gaarde, 2016) have been implemented 
at Holden Comprehensive Cancer Center to have a nurse-led exercise intervention for 
cancer survivors. Huether et al. (2016) noted that the oncology nurse is in an excellent 
position to assess CRF, educate patients, and follow up with patients to increase 
adherence.  
Another example, in the National Action Plan for Cancer Survivorship, published 
by the Centers for Disease Control and Prevention (CDC) in conjunction with the Lance 
Armstrong Foundation, one of the action steps is to establish a base of applied research 
and knowledge focusing on the issues of cancer survivors. Another action step is to 
implement effective programs to address survivors more completely (CDC, 2004). These 
initiatives direct the focus of nursing research. My project is a literature review focused 
on CRF in breast cancer patients. The results of this literature review will contribute to 
the research and knowledge that is called for in the National Action Plan for Cancer 
Survivorship. Similarly, the results of this literature review could help health care 
providers in implementing an effective program to address cancer survivor’s needs by 
prioritizing the assessment of CRF (Weis, 2011). 
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Transferability 
The findings of this study have transferability to similar practice areas. CRF is not 
an isolated symptom but can have adverse effects on functional status, mood, well-being, 
distress level, and sleep (Mitchell, 2015). CRF is highly subjective with some patients 
reporting excessive need to rest, whereas others characterize it as loss of efficiency or a 
mental fogginess (Mitchell, 2015). The experience of CRF is not isolated to breast cancer 
survivors but can occur at any point in the cancer trajectory and can affect cancer 
survivors of all types (Kantor & Suzan, 2016). CRF is often underreported and 
undertreated. Studies have concluded that one of the reasons for this underreporting and 
undertreating stems from difficulties in defining and accurately measuring CRF (James et 
al., 2015). The results of this project could be transferred to other disciplines that work 
within the multidisciplinary cancer survivor clinic. This includes the social worker, 
nutritionist, pastoral care, counselors, and physical therapists. CRF is a multidimensional 
problem with physical elements, emotional elements, and cognitive components (James 
et al., 2015). Being able to fully assess CRF will allow the different professionals 
working with this population to understand the severity of symptoms the patient may be 
experiencing. A multidisciplinary approach to treating the CRF can then be created to 
address the patient’s individual needs. 
Social Change 
This project supports the mission of Walden University by promoting positive  
social change. The concept of social change refers to the promotion of the “worth, 
dignity, and development of individuals” (Walden University, 2017a). Persistent CRF 
8 
 
can negatively affect the cancer survivor’s well-being and QOL (Mitchell, 2015). 
Therefore, CRF influences the individual’s perception of self-worth and dignity. By 
accurately assessing and measuring CRF in breast cancer survivors, health care providers 
can then use these measures to determine efficacy of interventions. 
Summary 
Breast cancer survivors are a growing population with unique needs. CRF is a 
prevalent symptom in this population and can negatively affect QOL (Appling et al., 
2012). Researchers have studied CRF and assessment strategies have been proposed, but 
consensus does not exist on the ideal assessment strategy for the survivor population 
(Noonan, 2016). Through this project, which is a systematic review of the literature, I 
will aid in identifying an appropriate assessment method. Once identified, this assessment 
method can be implemented into clinical practice. Giving nurses the tool to assess CRF is 
the first step in the nursing process. In the next section, I will discuss, in further detail, 
the background, supporting theories, relevance, context, and roles. 
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Section 2: Background and Context 
Introduction 
There is an ever-growing population of breast cancer survivors with a unique set 
of clinical needs. A prevalent symptom in this group of patients is persistent CRF (Wang 
& Woodruff, 2015). However, currently no consensus exists on the best method of 
assessing CRF in breast cancer survivors (Noonan, 2016). Therefore, my purpose in this 
project was to identify the best method of assessing CRF in breast cancers survivors and 
to develop a plan for dissemination of findings and implementation in the survivor clinic. 
The practice-focused question was: What is the most appropriate way to assess fatigue in 
breast cancer survivors? 
In the first section of Section 1, I discuss relevant theories and models that I used 
to understand my research problem; I also provide definitions of important concepts. 
Second, I present of the relevance of this project to nursing practice in general. Third, I 
provide a description of the local context. Last, I discuss my role as a doctor of nursing 
practice (DNP) student, including my motivations and potential biases. 
Concepts 
Two key concepts were central to this project: CRF and cancer survivorship. The 
backbone of any scholarly project is the core concepts of interest because concepts are 
the building blocks of models and theories. The operational definition of a concept must 
be clear so that the connections between the concepts can be made (Doyle, 2008). The 
following is a summary of concept analyses for CRF and cancer survivorship. These are 
the 2 key concepts in the practice-focused question, central to the project. 
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Cancer-Related Fatigue 
Historically, the concept of CRF has been difficult to clarify. This lack of 
clarification has resulted in inconsistencies in the definition and the instruments proposed 
to measure CRF. Fatigue is a common symptom of illness in general, not only of cancer, 
and has been used interchangeably and erroneously with tiredness or weakness (Ream & 
Richardson, 1996). Further study has characterized CRF as feelings of tiredness, 
weakness, and lack of energy. In addition, CRF interferes with usual functioning and 
QOL and does not correlate with the level of exertion (Hofman, Ryan, Figueroa-Moseley, 
Jean-Pierre, & Morrow, 2007). CRF is complex, subjective, and multidimensional, and it 
is best measured by self-report from patients (Ream & Richardson, 1996).  
For this project, I used a recent definition proposed by ASCO. CRF is “a 
distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness 
or exhaustion related to cancer and/or cancer treatment that is not proportional to recent 
activity and interferes with usual functioning” (Bower et al., 2014, p. 1844). This 
definition combines an understanding of the many attributes of CRF as well as the 
potential ramifications in all areas of life. This definition also highlights the subjective 
nature of CRF and that it affects patients’ functioning in daily life and must be addressed 
by clinicians (Bower et al., 2014). 
Cancer Survivorship 
The second concept that requires precise definition for my project is cancer 
survivorship. Attention to cancer survivorship is credited to physician and cancer 
survivor Mullan. In the book, Seasons of Survival, the author described three periods in 
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survivorship: acute, extended, and permanent (1985). Survivorship begins with diagnosis 
and continues for the remainder of life (Doyle, 2008). Further definitions of this concept 
extended the criteria to inclusion of caregivers, friends, and family because of the effects 
of cancer diagnosis and treatment on them by proxy of their loved ones. Often, an 
undercurrent of battle themes occurs in discussions of survivorship, described as 
‘winning the fight’ against cancer (Hebdon, Foli, & McComb, 2015). 
For the purposes of this project, I used the following definition that has been 
proposed by the National Coalition for Cancer Survivorship (NCCS). NCCS defines 
someone as a cancer survivor from the “time of diagnosis and for the balance of life 
[and] to include family, friends, and caregivers” (Twombly, 2004, para. 6). This 
definition is concise, accepted widely by the cancer community, and endorsed by ASCO 
(ASCO, n.d.). 
With improvements in screening, early detection, and treatment, there is an ever-
increasing cancer survivor population. This has created a shift in perspective regarding 
cancer survivorship. For example, breast cancer is no longer a completely fatal disease. 
Cancer survivorship is considered, by clinicians, to be a long-term chronic disease 
(Cheung & Delfabbro, 2016). As with any chronic disease, patients can experience a 
wide range of issues and challenges. Cancer survivors may experience persistent fatigue, 
physical changes, fear of recurrence, late- and long-term effects of cancer treatment, and 
an expectation to get back to ‘normal.’ During survivorship, the patient is no longer in 
active treatment and therefore no longer being seen by the treatment team on a regular 
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basis; this reduction in care can be experienced as a removal of a perceived ‘safety net’ 
(Kantor & Suzan, 2016). 
There is a growing focus on understanding and addressing survivorship. This 
focus stems from the many health problems that survivors can face as a consequence of 
their illness, their treatment, pre-existing conditions, and normal aging-related changes. 
To support the complex care of cancer survivors, ASCO published The Survivorship 
Curriculum (2016). The curriculum outlines the essential elements of survivorship care 
including surveillance for recurrence and second cancers, treatment of long-term and late 
effects of cancer treatments, health promotion and disease prevention, psychosocial well-
being, and communication and care coordination (Shapiro et al., 2016). 
CRF is a common and disruptive symptom experienced by cancer survivors. The 
source of the fatigue is not clear. It could be a consequence of the cancer itself, or the 
treatments, but generally resolves after end of treatment and cure of cancer (Corbett, 
Groarke, Walsh, & McGuire, 2016). However, it is estimated that at least 30% of cancer 
survivors struggle with CRF for years after completing treatment for their cancer. 
Patients report not being prepared for the experience of persistent fatigue often leading to 
confusion, isolation, and frustration (Corbett et al, 2016). 
Theory 
Health as Expanding Consciousness 
The Health as Expanding Consciousness theory was developed by Newman and 
stems from Rogers’s theory of unitary human beings (Petiprin, 2016). The theory 
proposes that defining health as the absence of disease is problematic because some 
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individuals must deal with chronic diseases, so absence of a disease is not a possibility. 
Yet, health, or thinking of oneself as healthy, should be a possibility for all individuals. 
Theorists of HEC posit that every person, regardless of disease status, is part of the 
universal process of expanding consciousness (Petiprin, 2016). This expanding 
consciousness, according to the theory, leads to a better understanding of oneself, finding 
greater meaning in life, and connecting with the others and the world. Within the HEC 
and the unitary-transformative paradigm, nursing is an opportunity to partner with 
patients and their families and participate in transformative encounters (Doyle, 2008).  
In a concept analysis of cancer survivorship, Doyle (2008) applied HEC to the 
cancer survivorship period. Describing survivorship as a process that starts at diagnosis 
and extends past treatment. The survivorship period and process can allow for a new 
synthesized view of self, incorporating chronic illness and disease as a meaningful aspect 
of health (Doyle, 2008). 
Cancer survivors are living with a chronic disease. Yet, according to HEC, 
survivors can view themselves as healthy (Petiprin, 2016). Cancer survivors can 
participate in the universal process of expanding consciousness and thus be able to find 
greater meaning in their life and reconnect with the world around them, regardless of 
disease state (Kantor & Suzan, 2016). Nurses can engage with patients about their 
experience within the context of expanding consciousness helping the patient cope and 
recover. 
In 1990, Newman developed a research method based on HEC called the praxis 
method. The focus within the praxis method is the integration of theory, research, and 
14 
 
practice into a unitary perspective. It requires the researcher-practitioner to be 
authentically present with the client-participant in searching for life patterning (Smith, 
2011). Research using HEC and the praxis method is growing and is being used 
internationally, indicating a global appeal and that the concepts in the theory transcend 
cultural differences (Endo, Miyahara, Suzuki, & Ohmasa, 2005; Smith, 2011). 
HEC has been used to study many chronic illness and distressing situations. These 
include the study of coronary heart disease, HIV/AIDs, COPD, rheumatoid arthritis, 
multiple sclerosis, schizophrenia, weight loss, dementia, bipolar disease, menopause, 
smoking cessation, and health care disparities. This range of focuses indicates that HEC 
is widely applicable in nursing (Smith, 2011). 
Moch (1990) used HEC to explore the experience of health for patients with 
breast cancer. Patterns of expanding consciousness emerged as a result of the tension 
created by illness. This expanding consciousness then facilitated change and 
connectedness between the person and environment (as cited in Smith, 2011, p. 264). 
Newman (1995) used HEC to explore the meaning of the life pattern of persons 
diagnosed with cancer. The diagnosis of cancer in these patients led to a turning point in 
life that, for some, resulted in authentic living and more meaningful connections with 
others (as cited in Smith, 2011, p. 264). Karlan, Jankowski, and Beal (1998) used HEC to 
explore the experiences of childhood cancer survivors. The experience of cancer as a 
child promoted expanded consciousness and life patterns of hope, optimism, empathy, 
and family bonds (as cited in Smith, 2011, p. 265). Kiser-Larson (2002) used HEC to 
understand life patterning in Native American women with breast cancer. The diagnosis, 
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for these women, led to chaos and a turning point that led them to deeper meaning in life 
and spirituality (as cited in Smith, 2011, p. 267). 
Endo has used HEC in the study of cancer and the nurse-client relationship 
(1998), family-nurse relationship (2000), praxis methods (2005), and smoking cessation 
(2009) (Smith, 2011). Endo (2017) specifically applied HEC to cancer and the nursing 
process. The nurse, or provider, and the patient enter into a mutual process of pattern 
recognition leading to a higher level of consciousness. This is called the ‘caring 
partnership,’ which then facilitates the development of interventions that focus on the 
patient as a whole and the patient’s meaning in the experience. The caring partnership is 
recommended to nurses and doctors who care for cancer patients. The partnership will 
lead to better understanding by both parties and personal growth through difficult 
situations (Endo, 2017). 
Mishel’s Theory of Uncertainty in Illness 
Cancer survivors experience uncertainty about their disease and its potential 
trajectory, what extended survival will look like and the ever present fear of recurrence. 
There is ambiguity surrounding this chronic illness state, complicated by treatments, 
information gaps, and unpredictable disease course. This uncertainty may lead to positive 
or negative coping strategies (Hebdon et al., 2015). 
This uncertainty is explained by Mishel’s uncertainty in illness theory. Developed 
by Mishel in the 1980s, the theory attempts to address the issue of uncertainty in chronic 
illness and coping with that uncertainty. The theory posits that uncertainty in illness can 
be viewed as a threat or an opportunity, leading to positive and/or negative coping 
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strategies to reduce the threat and/or enhance the opportunity. Mishel further stated that 
accepting uncertainty as a fluid state and view it as leading to more possibilities and new 
patterns of thinking in living is essential to coping with chronic illness (Mishel, 1990). 
The theory of uncertainty in illness has been studied extensively in many illness 
states to include heart transplant, myocardial infarction, cardiac surgery, bowel resection, 
COPD, cystic fibrosis, scoliosis, end-stage renal disease, and multiple sclerosis. It has 
been studied in children, adolescents, and adults with cancer and among cancer survivors. 
(Neville, 2003). The perception of uncertainty is identified as one of the major problems 
of cancer survivors. This uncertainty can influence stress appraisal, coping, and hope 
(Wonghongkul, Moore, Musil, Schneider, & Deimling, 2000). Uncertainty may become 
integrated into daily existence and has been associated with poorer QOL in breast cancer 
survivors (Tramm, McCarthy, & Yates, 2012). 
Wonghongkul, Dechaprom, Phumivichuvate, and Losawatkul (2006) investigated 
the relationship between uncertainty, coping, and QOL among early (3 years after 
diagnosis) breast cancer survivors. A moderate level of uncertainty was found among the 
participant and the longer the survival time the less uncertainty they reported. Uncertainty 
can be mitigated by education, familiarity, and social support (Wonghongkul, 
Dechaprom, Phumivichuvate, & Losawatkul, 2006). Miller (2014) applied the theory of 
uncertainty in illness to information seeking in cancer survivorship. The chronic presence 
of uncertainty in cancer survivorship can lead to or contribute to distress for the patient 
and the patient’s family and caregivers. Communication with the health care team can 
reduce uncertainty but too much information can complicate the uncertainty (Miller, 
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2014). Therefore it is imperative for nurses and providers to establish a relationship with 
patients, to understand their unique information needs. This facilitates viewing 
uncertainty as more possibilities rather than a threat (Mishel, 1990). 
Both the HEC and the theory of uncertainty in illness focus on building 
relationships with patients to help them better understand their chronic illness and then 
better cope with the consequences of the disease (Endo, 2017; Miller, 2014). Both 
theories are applicable to the study of CRF. Using the HEC nurses can form caring 
partnerships with cancer survivors to explore the meaning of the fatigue according to the 
patient. Then using, the theory of uncertainty in illness, nurses can help the patients 
understand the fatigue and its source then work together to build a care plan to aid in 
coping and recovery. 
Relevance to Nursing Practice 
Cancer survivorship is a relevant issue to nursing practice because of the 
increasing number of cancer survivors. The American Cancer Society estimates that more 
than 1.3 million people were diagnosed with cancer in 2005 (Hofman et al., 2007). This 
number is still increasing. In 2012, approximately 13.7 million people were living with a 
history of cancer. This is projected to increase to 18 million by 2022 (Hebdon et al., 
2015). The growing prevalence of patients with a history of cancer presents new 
challenges for nursing practice to “identify and manage treatment-related sequelae, 
enhance QOL, and improve the overall functioning” (Jones et al., 2016, p. 52). 
In a survey of 763 breast cancer survivors 35% reported experiencing fatigue at  
1-5 years post-treatment, 34% at 5-10 years post-treatment, and 21% report experiencing 
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fatigue at both measurement points (Hofman et al., 2007). Fatigue is a persistent, 
debilitating, distressing symptom in a significant portion of cancer survivors (Hofman et 
al., 2007). Similarly, in a study of fatigue and disability Jones et al. (2016) found that 
CRF was still present 6 years post-treatment and was most common among breast and 
colorectal cancer survivors. CRF is reported by survivors as the most distressing 
symptom, having greater negative effect on cancer survivors’ QOL than pain, depression, 
and nausea. In addition, other complications of fatigue include: impairment in ability to 
perform activities of daily living, increased levels of anxiety, mood disturbance, loss of 
work days for patients, family members, and care givers (Hofman et al., 2007). Research 
suggests that cancer survivors utilize primary care more frequently than age-matched 
controls and use it for the primary complaint of fatigue. Still, CRF is underreported, 
underestimated, and undertreated and represents a poorly managed problem for cancer 
survivors (Jones et al., 2016). 
The Institute of Medicine (IOM) issued a mandate to nurses to “promote 
evidence-based, comprehensive, compassionate, and coordinated survivorship care” 
(Hewitt, Greenfield, & Stovall, 2005). Surviving cancer is now a reality for millions of 
people and fatigue is a significant and distressing for these millions (Shapiro, et al., 
2016). In order to fulfill the IOM’s mandate for ‘comprehensive’ survivorship care, 
nursing care must address CRF. Unfortunately, there is no single standardized CRF 
measure for breast cancer survivors that has been widely adopted (Wang & Woodruff, 
2015).  
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CRF is not a new practice issue for nurses. Previously, there have been attempts 
to address this problem. One of the first fatigue assessment scales is the Symptom 
Distress Scale, developed in 1978. This scale consists of a 13-item self-report Likert scale 
for characterizations of multiple cancer related symptoms to include fatigue but also pain, 
insomnia, activity, concentration, mood, and appearance. More focused assessments were 
also developed such as the Fatigue Scale and Fatigue Observation Checklist ( in 1982), 
the Piper Fatigue Scale (in 1989), the Multidimensional Assessment of Fatigue (in 1991), 
and the Visual Analog Scale for Fatigue (in 1999). These tools vary in construction, 
number of items, and the type of scale used. There are barriers to consistent selection 
among these scales such as: measurement model for statistical analysis, evidence of 
validity, practicality, psychometric soundness, ease of understanding, ease of use, and 
standardized rules for administration and scoring (Wang & Woodruff, 2015). Other 
fatigue scales include the Fatigue Symptom Inventory (FSI), the Medical Outcome Study 
Short Form-36 Health Survey, and the Profile of Mood States (POMS). However, it is 
unclear which of these scales is the best instrument for detection of CRF in active cancer 
patients as well as cancer survivors (Goedendorp, Jacobsen, & Andrykowski, 2016). 
Patients are unaware of the potential long-term effects of cancer treatment on their 
lives and there is need for high quality care after the active treatment phase (James et al., 
2015). The physiology and psychosocial burden of fatigue for cancer survivors is high, 
leading to increased disability that has a negative effect on QOL and ability to perform 
normal daily activities and be active participants in life. Disability is as important as 
mortality and cancer research efforts have reduced mortality, but not the morbidity 
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associated with the disability of CRF. Further efforts are needed to detect and treat the 
persistent and late effects of cancer (Jones et al., 2016). 
Local Background and Context 
Hebdon (2015) identified 3 P’s of cancer survivorship care: palliation of 
symptoms, prevention of recurrence and late effects, and promotion of wellness. 
Addressing CRF serves to fulfill all of the 3 P’s of survivorship. In 2015, a pilot study 
was conducted to identify factors contributing to diminished sexual functioning in breast 
cancer survivors (Makhoul et al., 2016). The researchers surveyed survivors and their 
partners to discover what potential late and long-term effects may be effecting QOL. 
They discovered that one of the most reported symptoms affecting sexual function was 
fatigue (Makhoul et al., 2016). Fatigue as a contributing factor to sexual dysfunction was 
not the expected outcome. There was not specific interest in CRF but rather interest into 
QOL and sexual functioning.  
Nurses play a key role in the management of fatigue through promoting open 
communication between patients and clinical providers. This helps to identify the 
problem, reduce anxiety, explore the disease process, set realistic expectations, and helps 
to promote meaningful interactions with dignity (Kantor & Suzan, 2016). The cause of 
CRF is multifactorial and complex with components of pathology, psychology, situation, 
metabolism, and mood disturbance (Jones et al., 2016). This project will help nurses 
fulfill their role in the management of CRF by helping nurses to identify the problem and 
explore the disease process through the assessment of CRF. Also, this project will 
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provide a consistent way to monitor the effectiveness of interventions aimed at 
addressing CRF. 
The state’s medical oncology division at the cancer center participates in ASCO 
Quality Oncology Practice Initiative (QOPI). This program helps to promote a culture of 
improvement within the outpatient oncology practice. Participants can report on certain 
quality measures and become QOPI certified. These quality measures can be used as a 
measure of performance and can aid in the development and implementation of quality 
improvement projects leading to better outcomes and better patient care (ASCO.org, 
2018). One of the quality domains reported to QOPI and used for certification 
designation is reporting on efforts for symptom management for breast cancer survivors. 
CRF is a symptom in breast cancer survivors and the results of this project will aid nurses 
in the assessment of CRF, thus improving the quality of care for the breast cancer 
survivors at this site and meeting the criteria for QOPI. 
ASCO, NCCN, and the Canadian Association of Psychosocial Oncology (CAPO) 
have developed guidelines on the treatment of CRF during active treatment. It should be 
routinely assessed and measured on a scale of 0-10 with a cutoff of 4 signaling more 
action needed. Treatment starts with a comprehensive assessment of all contributing 
factors, specifically functional status, nutrition, exercise, and sleep. Approaches to 
mitigate CRF include patient education, cognitive behavioral therapy, sleep hygiene, and 
physical activity. There is no consensus on the best measurement of CRF and its 
multifactorial origins, nor is there consensus on the gold standard of treatment (Jones et 
al., 2016). 
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Treatment of CRF can be costly and time consuming. It is important to be mindful 
of resources in health care. Therefore it is important to be able to identify clinically 
significant cases of CRF. This will enable nurses to target those patients in need of 
treatment for CRF. A method for efficiently and accurately screening large patient 
populations such as cancer survivors is needed (Goedendorp et al., 2016). 
Also, the state’s cancer center is striving for National Cancer Institute (NCI) 
accreditation. This is a rigorous accreditation process that recognizes the cancer center as 
prestigious and contributes to its support, funding, and increased access to clinical trials. 
To become accredited a cancer center must prove that it is contributing to the fight 
against cancer and be a center for ground-breaking treatments and quality care for the 
community (“NCI-Designated Cancer Centers”, n.d.). This project contributes to the NCI 
accreditation effort in that the results will help to improve the quality of care for the 
community by improving the assessment of CRF in breast cancer survivors. 
Role of the DNP Student 
My professional context is that I am the advanced practice registered nurse 
(APRN) in the UAMS-WPRCI survivor clinic. I am charged with addressing the 3 P’s of 
cancer survivorship for my patients who come from all over the state of Arkansas. My 
relationship or role in the doctoral project is that I will be conducting the systematic 
review of the literature. This topic is important to me because it is integral in addressing 
QOL for my patients. I am a member of the ACC and am passionate about improving the 
lives of cancer survivors in Arkansas. My professional mentor was the primary 
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investigator in the previously mentioned pilot project conducted at UAMS and is the one 
who brought this issue to my attention. 
Any researcher or project is subject to potential bias. Bias is “any tendency to 
which prevents unprejudiced consideration of a question” (Pannucci & Wilkins, 2010, p. 
1). This can occur in any phase from planning, to data collection, to interpretation. It is 
important not only to ask if bias is present or not but to consider how it can be prevented 
by proper design and diligent implementation (Pannucci & Wilkins, 2010). The design of 
this project is a systematic review of the literature. There is potential for inherent bias 
with this type of project in the selective inclusion or exclusion of studies to support the 
authors’ views. To reduce the potential for bias it is important to follow a structured, 
transparent, and recorded process. In this way, any other reviewer could follow the same 
steps, with the same resources, and reach the same conclusions (Walden University, 
2017b). 
Summary 
In this section of the paper, I defined the concepts that are central to the project. 
As well as the underlying theories. Then, I expanded on the relevance to nursing practice 
as well as the local background and context. Finally, I clarified my role as the DNP 
student, including motivations and potential biases. In the next section, I will address the 
practice-focused question, the sources of evidence that I used including published 
resources and outcomes, and the systems that I used for data analysis and synthesis. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
The problem that I addressed in this project is that no consensus exists on the best 
method of assessing CRF in breast cancer survivors. Many models and scales are 
available to measure CRF for patients on active treatment but not for survivors (Noonan, 
2016). CRF is one of the most commonly reported symptoms for breast cancer survivors 
and can negatively affect QOL and coping for patients and families (Appling et al., 
2012). My purpose in this project was to conduct a systematic review of the literature to 
identify the best method of assessing CRF in breast cancer survivors and to develop a 
plan for dissemination of the findings for implementation in the survivor clinic. 
Due in part to better screening, early detection, and improved treatments, there is 
an ever-increasing number of cancer survivors. The American Cancer Society estimates 
that 18 million people will be living with a history of cancer by the year 2022 (Hebdon et 
al., 2015). Fatigue is a persistent, debilitating, distressing symptoms in a significant 
portion of cancer survivors (Hofman et al., 2007). The IOM issued a mandate to nurses to 
“promote evidence-based, comprehensive, compassionate, and coordinated survivorship 
care” (Hewitt et al., 2005, p.19). To fulfill this mandate and provide quality patient care 
to the unique population of cancer survivors, nurses need a tool to properly assess CRF. 
In Section 3, I reiterate the practice-focused question and the gap in practice that I 
addressed in this project. I clarify the purpose, alignment, operational definitions, and key 
aspects of the project. Further, I elaborate on the sources of evidence, data collection, and 
analysis methods. Finally, I describe the system for organizing and tracking the evidence. 
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Practice-Focused Question 
The practice-focused question that I addressed in this study was the following: 
What is the best method to assess CRF in breast cancer survivors? A pilot study of breast 
cancer survivors and their partners found that fatigue is one of the most reported 
symptoms negatively affecting sexual functioning and QOL (Makhoul et al., 2016). 
These results illuminated a gap-in-practice in the management of CRF. Nurses play a key 
role in the management of fatigue by promoting open communication between patients 
and clinical providers to identify the problem, reduce anxiety, explore the disease 
process, set realistic expectations, and promote meaningful interactions and dignity 
(Kantor & Suzan, 2016). The results of this project will help nurses fulfill their role in the 
management of CRF. 
My purpose in this project was to identify the best method of assessing CRF in 
breast cancer survivors and to develop a plan for dissemination of the findings and 
implementation in the survivor clinic. Identifying the best method of assessment for this 
population will enable nurses to identify the problem, better explore the disease process, 
and provide a consistent way to monitor the effectiveness of interventions aimed at 
addressing CRF. The approach that I used for this project was a systematic review of the 
literature organized around the central concepts of CRF and breast cancer survivors. 
For the purposes of this project, CRF was defined as “a distressing, persistent, 
subjective sense of physical, emotional, and/or cognitive tiredness or exhaustion related 
to cancer and/or cancer treatment that is not proportional to recent activity and interferes 
with usual functioning (Bower et al., 2014, p. 1844).” The term cancer survivor as 
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defined by NCCS is someone from the “time of diagnosis and for the balance of life,” 
and “to include family, friends, and caregivers” (Twombly, 2004, para. 6). 
Sources of Evidence 
Many potential sources of evidence exist to address this question. First, textbooks 
have been written on survivorship care and oncology symptom management. These were 
a foundational source to establish what is already known on the topic of CRF. The 
bibliography sections of these texts also provided further background literature to allow 
me to fully understand the scope of the problem and what has been done so far to address 
the problem. The next step was to conduct a multidatabase search through Thoreau and 
the Walden Library. This provided the bulk of the literature for the systematic review. It 
clarified what is being done now to address the problem and what assessment methods 
are being used. Finally, I consulted the websites of various professional organizations for 
practice standards and guidelines, for example, ONS, ASCO, NCCN, and APSHO. I 
included these guidelines in the systematic review and highlighted what experts in the 
field view as the appropriate standard of care for the problem. 
Published Outcomes and Research 
For this systematic review, I followed the steps detailed in the Walden University 
manual for systematic reviews. The first step was to identify the scope of the review; this 
included the list of databases and search engines, key search terms, scope of review, and 
clarity on how the search would be exhaustive and comprehensive (Walden, 2017b). I 
accessed the databases through the Walden Library’s Thoreau multidatabase search tool. 
Available databases included CINAHL, MEDLINE, Ovid, ProQuest, PubMed, Annual 
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Reviews, BioMedCentral, Cochrane, ScienceDirect, Database of Systematic Reviews, 
Joanna Briggs Institute EBP Database, Merck Manual, and the Directory of Open Access 
Journals.  
The Google search engine proved helpful to explore the NCCN, ASCO, ONS, and 
the APSHO guidelines. I also used Google Scholar to search for guidelines and articles. 
Key search terms included cancer-related fatigue OR cancer related fatigue AND breast 
cancer survivor AND assessment. Literature included in the review was published within 
the last 5 years, in English, and with full text available. Sources included peer-reviewed 
scholarly journals and professional organizations published guidelines. The search was 
exhaustive and comprehensive in that I continued until I found no new results, indicating 
saturation in the searches. 
The second step was to formulate the review question (Walden, 2017b): What is 
the best assessment method of CRF in breast cancer survivors? The third step was to 
define explicit inclusion and exclusion criteria. The exclusion criteria consisted of no free 
full text available, being written in a foreign language, being older than 5 years, and not 
using a fatigue measurement instrument. 
The fourth step was to perform a comprehensive search to find all relevant 
studies. In this step, the systems used for recording, tracking, and organizing the evidence 
and the procedure must be explicit to assure the integrity of the evidence (Walden, 
2017b). The system for recording and tracking the evidence is the PRISMA flow diagram 
(see Appendix A). PRISMA stands for Preferred Reporting Items of Systematic reviews 
and Meta-Analyses. Developed by an international work group of researchers to address 
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the quality of reporting of results of systematic reviews and meta-analyses, this reporting 
system consists of a checklist and four-phase flow diagram to display the flow of 
literature through the systematic review process. It is not a quality assessment tool 
(Moher et al., 2015). 
A systematic review of the literature is not a summary of research articles but a 
synthesis of ideas and themes from the literature. The system for organizing the evidence 
was a literature review matrix, which aids in creating a comprehensive, fair, and balanced 
literature review. This technique can help identify gaps in research and identify diverse or 
conflicting findings (Clark & Buckley, 2017). I created the matrix in Microsoft Excel and 
included columns for details such as title, author, year, publication, database, DOI, 
keywords, summary, strengths, weaknesses, and the reference as well as common themes 
and main ideas. In addition, I stored each source and reference in Mendeley citation 
management software (see Appendix B). 
Analysis and Synthesis 
The fifth step for a systematic review was to select the studies, and then the sixth 
step was to appraise the studies for quality (Walden University, 2017b). Failure to 
recognize and differentiate between high- and low-quality evidence can contribute to 
errors in the care and management of patients. Judgment is needed in the interpretation of 
evidence, and the GRADE method can help in this interpretation (Guyatt et al., 2008). 
Therefore, I analyzed the literature that I discovered in this review using the GRADE 
method. 
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GRADE is a process for addressing the quality of the evidence and strength of the 
evidence. Some advantages of GRADE include that it addresses quality and strength, 
provides explicit criteria for each level of evidence, delineates a transparent process, 
allows for clear interpretation of strong versus weak evidence and is useful for multiple 
types of evidence and studies such as the systematic review (Guyatt et al., 2008). Using 
the GRADE method, the researcher classifies each piece of evidence into one of four 
levels of evidence: high, moderate, low, and very low (Guyatt et al., 2008). High-quality 
evidence means that further research is not likely to change the confidence in the 
evidence (Guyatt et al., 2008). Moderate-quality evidence means further research is likely 
to affect the confidence in the evidence (Guyatt et al., 2008). Low-quality, sometimes 
combined with very low-quality, evidence means that further research is very likely to 
change the confidence level in the evidence (Guyatt et al., 2008). 
GRADE has been adopted by more than 100 organizations globally, including the 
World Health Organization, National Institute for Health and Care Excellence, and the 
European Union (EU). For example, the EU used GRADE to develop the Evidence to 
Decision (EtD) framework to support the process of going from evidence to decisions. 
The EtD framework based on the GRADE method is a transparent, systematic, and 
explicit process for judging the evidence (Alonso-Coello et al., 2016). 
I completed the remaining steps in the literature review process at the same time 
that I filled out the literature review matrix and applied the GRADE criteria. These steps 
include (a) identify what is known on the topic, (b) analyze relevant studies, (c) 
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summarize and GRADE studies in the review matrix, (d) synthesize the results, (e) 
interpret the results, and finally (f) present the results (Walden University, 2017b). 
Summary 
To improve the care provided to breast cancer survivors, it is imperative for 
nurses to address their patients’ needs. One of the most persistent distressing issues 
facing these patients is CRF. A method to adequately assess this issue is needed. This 
project was a systematic review of the literature to identify the best method of assessing 
CRF. Using multidatabase searches, search engines, and library resources I gathered and 
organized the evidence then analyzed the evidence using GRADE criteria. 
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Section 4: Findings and Recommendations 
Introduction 
CRF is often described as an “overwhelming or all-embracing feeling of tiredness, 
weariness, exhaustion, and malaise which usually cannot be relieved by sleep or rest” 
(James et al., p. 2089, 2015). CRF is a debilitating and persistent symptom into the 
survivorship period negatively effecting QOL (Mitchell, 2015). To provide effective care 
to breast cancer survivors, nurses need to be able to identify significant cases of fatigue 
and perform an evidence-based assessment of fatigue. Although many models and scales 
are available to measure CRF for patients undergoing active treatment, a lack of 
consensus exists on an appropriate method to assess CRF in breast cancer survivors 
(Noonan, 2016). This represents a gap in practice. This project is a systematic review of 
the literature whose purpose is to address this gap in practice and to answer the practice-
focused question: What is the best method to assess CRF in breast cancer survivors? 
The sources of evidence for this systematic review of the literature include 
multiple scientific databases accessed through Walden Library’s Thoreau search tool and 
published guidelines from professional organizations. After obtaining the evidence online 
following a logical PRISMA flow diagram, I organized the evidence in a literature review 
matrix and analyzed it using GRADE criteria. I managed the citations using Mendeley 
software. 
Findings and Implications 
The Thoreau search criteria included the terms cancer-related fatigue OR cancer 
related fatigue AND breast cancer survivor AND assessment. The search mode was 
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Boolean with limits set at full text available, published in 2012 or after, peer-reviewed, 
academic journals, and available in English. In this search, I found 17 articles. I found an 
additional seven records through the websites of the ONS, ASCO, NCCN, and Cochrane 
review. After removing duplicate records, 23 remained. I then screened these 23 and 
removed nine records. Two records removed for being focused on health-related QOL 
and not on fatigue. Two others removed for being examples of fatigue scales and not 
examples of their use. One record excluded for focusing on the etiology of CRF, 1 for 
focus on cancer-related cognitive impairment, 1 for focus on measuring acupuncture 
dose, and 1 for measuring inflammatory markers. Finally, 1 excluded because free full 
text was not available (see Appendix A). I then entered the remaining 14 into the 
literature review matrix (see Appendix B). In the following sections, I provide a 
description of each fatigue assessment tool and the article found in the literature review 
that used said tool. 
Profile of Mood States 
The POMS scale, originally developed in 1971 and consisting of 65 self-report 
items, each rate 0 (not at all) to 4 (extremely) (Spielberger, 1972). The items are divided 
into six subscales: tension-anxiety, depression-dejection, anger-hostility, fatigue-inertia, 
vigor-activity, and confusion-bewilderment. Administration time for healthy adults is 3 to 
7 minutes and for ill adults 15 to 20 minutes (Sacham, 1983). Internal consistency is 
Cronbach alpha 0.63 to 0.96. Correlation between subscales and total score was 0.84 
(Spielberger, 1972). Sacham (1983) abbreviated the scale into a short form of 37 items. 
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This decreased the administration time by half while maintaining internal consistency 
(Sacham, 1983). 
Goedendorp et al. (2016) used a cross-sectional analysis to determine the optimal 
cutoff scores for fatigue screening on the Medical Outcomes Study Short Form- 36 (SF-
36), FSI, and the POMS-fatigue. On the POMS-fatigue, higher scores mean greater 
fatigue. Goedendorp et al. concluded that brief, accurate screening can be done using 
POMS but that the FSI was found to be most accurate. Limitations include a homogenous 
sample and that the results were cross-validated using the same data from different time 
points (Goedendorp et al., 2016). 
36-Item Short Form 
The 36-item short-form (SF-36), developed for the Medical Outcomes Study by 
RAND health care in 1992, includes eight multiitem subscales (Ware & Sherbourne, 
1992). These subscales measure aspects of fatigue that include physical functioning, role 
limitations because of physical health problems, bodily pain, social functioning, mental 
health, role limitations because of emotional problems, vitality, and general health 
perceptions (Ware & Sherbourne, 1992). The scale can be self-administered or 
administered by a clinician. Each item is rated on a Likert scale using summated ratings. 
For healthy adults, the form can be completed in 5 to 10 minutes (Ware & Sherbourne, 
1992). Other measures of QOL include the 12- and 20-item short forms. All are derived 
from the core survey instrument of 116 measures of QOL and functioning (RAND 
Corporation, n.d.). 
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Again, Goedendorp et al. (2016) used a cross-sectional analysis to determine the 
optimal cutoff scores for fatigue screening on the SF-36, FSI, and the POMS-fatigue. The 
SF-36 measures vitality, and a lower score means less vitality, which is then interpreted 
as fatigue. Goedendorp et al. determined that brief, accurate screening can be done using 
SF-36 but, again, that the FSI was most accurate. The researchers also found that a 
limitation of the SF-36 is that is has reverse-worded items (Goedendorp et al., 2016). 
Functional Assessment of Cancer Therapy 
The Functional Assessment of Cancer Therapy (FACT), developed in 1994, 
measurement system is a component system consisting of a general scale (FACT-G) that 
measures health-related QOL and then disease-specific and symptom-specific subscales 
such as the fatigue subscale (FACT-F) (Yellen et al., 1997). FACT-G consists of 28 
items, self-report format, measured on a 5-point Likert scale. The questions assess 
physical well-being, social/family well-being, relationship with physician, emotional 
well-being, and functional well-being (Yellen et al., 1997). FACT-F consists of the 
original 34 items plus 13 items specific to fatigue. The combined scale has test-retest 
reliability of 0.87 and internal consistency with alphas = 0.95 (Yellen et al., 1997). The 
scale has been found especially useful in identifying the physical and functional 
component of fatigue (Yellen et al., 1997). 
Kaur, Gupta, Sharma, and Jain (2018) conducted a cross-sectional study to 
illuminate survivorship issues among Indian breast cancer survivors and effects on QOL. 
The fatigue measurement tool was the Functional Assessment of Cancer Therapy-Breast 
(FACT-B). This questionnaire consists of the FACT tool plus a fifth subscale specifically 
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for breast cancer and consisting of nine items. Kaur et al. found the most commonly 
reported survivorship issues include fatigue, shoulder restriction, body pain, joint pain, 
loss of sex drive, and chemotherapy-induced amenorrhea. This study, although the first to 
study this population, was more focused on overall QOL rather than CRF. Other 
limitations include the hospital setting limiting generalization to the ambulatory setting 
and being cross sectional, therefore lending no longitudinal data (Kaur et al., 2018). 
Revised Piper Fatigue Scale 
The revised Piper Fatigue Scale (PFS), developed by Piper in the 1997 as a 
shortened version of the original multidimensional PFS, contains 22 items in four 
subscales (Piper et al., 1998). These subscales look into the multidimensionality of 
fatigue by measuring behavior/severity, affective meaning, sensory, and cognitive/mood 
(Piper et al., 1998). Respondents rate each item on a scale of 0 to 10 and the overall scale 
was found to be reasonable in time for completion (Piper et al., 1998). The Cronbach’s 
alpha was retained at 0.92 after item reduction and the overall alpha coefficient was 
reliable at 0.97 (Piper et al., 1998). Piper et al. recommended screening for fatigue with a 
simple 0 to 10 severity rating and then further assessing those patients who report 
moderate to severe fatigue using the revised PFS (Piper et al., 1998). 
The PFS has been translated into multiple languages and the literacy demand for 
most items is an eighth-grade education (Reeve et al., 2012). A main concern with the 
PFS is respondent burden, so research has been done to reduce the number of items even 
further (Reeve et al., 2012). This resulted in a 12-item fatigue scale (PFS-12) that was 
36 
 
tested in a cohort of breast cancer survivors and found to be reliable and able to capture 
multiple aspects of fatigue while being more brief (Reeve et al., 2012). 
Galiano-Castillo et al. (2014) used a cross-sectional study to investigate the 
association between depressed mood and physical activity, CRF, QOL, and fitness level. 
CRF was measured using the PFS. The researchers found statistically positive 
correlations between depressed mood and level of CRF. Having CRF, low physical 
activity level, systematic side effects, and low body image were all predictors of 
depressed mood. Limitations to this study include the limited inclusion criteria, no causal 
relationship can be drawn, and the study did not consider other variables such as sleep 
(Galiano-Castillo, Ariza-Garcia, Cantarero-Villanueva, Fernandez-Lao, Diaz-Rodriguez, 
Arroyo-Morales, 2014). 
Hall, Mishel, and Germino (2014) conducted a cross-sectional analysis to 
investigate the relationship between survivorship-related functioning, fatigue, and 
uncertainty in younger breast cancer survivors. The revised PFS was used. The 
researchers concluded that fatigue is a persistent concern for survivors and is significantly 
related to uncertainty. Limitations to this study include the inability to draw causal 
relationship conclusions, and the use of self-report measures but no objective measures 
(Hall, Mishel, & Germino, 2014). 
Brief Fatigue Inventory 
The Brief Fatigue Inventory (BFI) was developed in 1998 and was based on the 
Brief Pain Inventory (BPI) with its simple wording and numerical scale from 0-10 
(Mendoza et al., 1998). The BFI consists of 9 items and assesses how the fatigue 
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interferes with general activity, mood, walking ability, normal work, relationships, and 
enjoyment of life (Mendoza et al., 1998). This scale was tested against the POMS and 
FACT-F scales and was found to be significantly correlated to each other (r = -0.88, p < 
.001 for FACT and r = 0.84, p < .001 for POMS) (Mendoza et al., 1998). The BFI also 
has internal consistency coefficient of 0.96. The scale is easily and quickly administered 
in clinic or clinical trials (Mendoza et al., 1998). However, it does not capture the 
multidimensional nature of fatigue and therefore may be most useful as a screening tool 
with a cut-off of 7 denoting severe fatigue that warrants further, lengthier investigation 
(Mendoza et al., 1998). 
Mao et al. (2018) conducted a cross-sectional analysis of breast cancer survivors 
on aromatase inhibitor (AI) therapy and the prevalence of fatigue. CRF was measured 
using the BFI. The researchers concluded that 4 in 5 patients on AI experience fatigue 
with 1 in 2 reporting moderate to severe fatigue. Limitations include potential for recall 
bias, decreased generalizability since only assessed those on AI, the BFI is not 
multidimensional, and with this design a causal relationship cannot be established (Mao 
et al., 2018). 
Smith et al. (2013) conducted a mixed method randomized controlled trial to 
investigate acupuncture on CRF. The fatigue measurement tool was the BFI. The 
researchers concluded that acupuncture is a feasible intervention and that the BFI is 
sensitive to changes in CRF over time. This study was of higher quality being a 
controlled trial and had good compliance with the intervention. However, recruitment 
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was slow, the study sample was small, the study had a short duration, and there was 
potential for a dose response bias (Smith, Carmady, Thornton, Perz, & Ussher, 2013). 
Fatigue Symptom Inventory 
The Fatigue Symptom Inventory (FSI) was developed in 1998 as a way to 
measure fatigue intensity and duration (Hann et al., 1998). The respondents rate their 
fatigue for the past week at its worst, least, and average on a 0-10 scale. It also consists of 
a 7 item subscale that assesses the amount of interference the fatigue had on general 
activity, activities of daily living, work, concentration, relationships, enjoyment, and 
mood, again on a 0-10 scale (Hann et al., 1998). The alpha coefficients for the 
interference subscale were high for each tested group (0.93-0.95). The test-retest 
reliability correlations were not as strong ranging from 0.1-0.75 (Hann et al., 1998). The 
FSI was correlated with the POMS, and SF-36. It was found to be acceptable to patients 
with low respondent burden (Hann et al., 1998). 
Again, Goedendorp et al. (2016) used a cross-sectional analysis to determine the 
optimal cutoff scores for fatigue screening on the SF-36, FSI, and POMS-fatigue. On the 
FSI higher ratings equates to greater severity or interference. The researchers concluded 
that while all three scales are brief and accurate the FSI was found to be most accurate. 
Limitations include a homogenous sample and that the results were cross-validated using 
the same data from different time points (Goedendorp et al., 2016). 
Multidimensional Fatigue Symptom Inventory-Short Form 
The Multidimensional Fatigue Symptom Inventory-Short form (MFSI-SF) was 
developed in 1998 to fill the need for a multidimensional scale (Stein, et al., 2004). It 
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consists of 30 items in 5 subscales measuring general fatigue, physical fatigue, emotional 
fatigue, mental fatigue, and vigor. Each item is a self-report measure using a 5-point 
Likert scale to indicate the extent to which the patient had the symptom the previous 
week (Stein, et al., 2004). Reliability coefficients for the subscales were 0.96 for general, 
0.85 for physical, 0.93 for emotional, 0.90 for mental, and 0.88 for vigor. The internal 
consistency alpha coefficients for each subscale were 0.96 for general, 0.92 for 
emotional, 0.87 for physical, 0.91 for mental, and 0.90 for vigor (Stein, et al., 2004). The 
MFSI-SF had high to moderate correlation with the FSI and SF-36. Advantages of this 
scale include the fact that it is multidimensional, not disease specific, it is brief, and has 
ease of response (Stein, et al., 2004). 
Stan et al. (2016). Conducted a pilot feasibility study to determine if a DVD 
guided home based yoga intervention versus a strength training intervention improved 
CRF and QOL. CRF was screened using the NCCN guidelines and then assessed in more 
detail using the MFSI-SF. The researchers concluded that both the yoga DVD and 
strength intervention were effective and feasible in improving CRF and QOL. Limitations 
of this study include lack of a non-intervention (control) group. There was also a small 
sample size, short follow-up period, lack of contact with the instructors, low adherence to 
the treatment, and difference in length of the 2 interventions. These limitations contribute 
considerably to bias and weaken the results (Stan et al., 2016). 
Cancer Fatigue Scale 
The Cancer Fatigue Scale (CFS) was developed in Japan in 1999 as a self-report, 
brief, multidimensional measure of fatigue for cancer patients (Okuyama, et al. 2000). 
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The scale consists of 15 items in 3 subscales of physical, affective, and cognitive 
dimensions. The maximum score is 28 with higher scores meaning more severe fatigue 
and average completion time is 132.9 seconds (Okuyama, et al. 2000). The Cronbach’s 
alpha coefficient were 0.90 for the physical subscale, 0.78 for the affective subscale, 0.79 
for the cognitive subscale, and 0.88 for the total scale. The CFS scores correlated with the 
visual analog scale (VAS) for fatigue scores (average r = .49, p < .001). The internal 
consistency coefficient was 0.89 for physical, 0.79 for affective, 0.79 for cognitive, and 
0.77 for total scale. The test-retest correlation coefficient for each factor compared the 
total score were all greater than 0.50 with a p < 0.001 (Okuyama, et al. 2000). 
Kroz et al. (2014) conducted a prospective observational study to investigate the 
effect of autonomic and self-regulation on CRF and distress. CRF was measured using 
the CSF-D with reliability reported at Cronbach’s alpha of r = .84-.94 and test-rest 
reliability of r = .73-.86. Distress was measured by the Hospital Anxiety and Depression 
Scale (HADS). The researchers concluded that reduced risk of CRF co-occurs with high 
autonomic regulation and high self-regulation is associated with reduced distress. 
Limitations include small cohort sample, no causation can be established, presence of 
selection bias with Caucasian only sample, and patient reported outcomes without 
objective measures (Kröz et al., 2014).  
In a different study, Kroz et al. (2017) conducted a cohort study to compare 
multimodal therapy (mindfulness and behavioral training) in combination with aerobic 
training to standard aerobic training alone to see which intervention had an effect on CRF 
and sleep. The researchers measured fatigue using the CFS-D in German. The researchers 
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found that multimodal was superior to aerobic therapy alone in reduction of CRF and 
improvement in sleep. Limitations to this study include small sample size, high drop-out 
rate, and use of the last-value-carried-forward technique. These limitations could lead to 
bias and decrease in generalizability (Kröz et al., 2017). 
Functional Assessment of Chronic Illness Therapy 
The Functional Assessment of Chronic Illness Therapy (FACIT) is a 
measurement system with a collection of questionnaires measuring different elements of 
QOL (Cella, et al., 2003). The original version was the FACT, previously described, 
developed in 1987. Now in its 4th version the FACIT-general questionnaire is used to 
assess physical well-being, social/family well-being, emotional well-being, and 
functional well-being (Cella, et al., 2003). The items on each subscale are rated on a 5-
point Likert scale with a high score being good. FACIT has been translated into 45 
different languages. Most questionnaires within FACIT can be completed in 5 to 10 
minutes. Contained within the FACIT scales collection are disease specific scales such as 
anemia, breast cancer, and colorectal cancer (Cella, et al., 2003). 
Lev-ari et al. (2013) conducted a descriptive study of a pilot program to 
investigate the use of meditation in improving well-being. CRF was assessed using 
FACIT. The researchers found an improvement in physical and mental health after 
intervention. However, limitations include no control group, a modest sample size and 
self-selected participants, no data over time, and reliance on self-report outcomes (Lev-
ari, Zilcha-Mano, Rivo, Geva, & Ron, 2013). 
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Jones et al. (2016) conducted a cross-sectional analysis to investigate the 
prevalence of CRF across time in breast, prostate, and colorectal cancer survivors. The 
researchers used the FACIT scale. The researchers concluded that fatigue scores were 
higher for breast and colorectal survivors but did not differ over time and that CRF can 
persist 6 years posttreatment. CRF was also found to be highly associated with disability. 
Limitations include the cross-sectional design which limits the ability to establish 
causation (Jones et al., 2016). 
Swen, Mann, Paxton, and Dean (2017) conducted a cross-sectional analysis to 
determine the association between physical activity level and fatigue level in African-
American breast cancer survivors. The FACIT was used to measure fatigue. The 
researchers found that less CRF was associated with more physical activity. This finding 
applied mostly to younger survivors (less than 50 years old). Limitations include the 
inability to establish a causal relationship, no differentiation between physical fatigue and 
emotional fatigue, self-reported data makes it more prone to recall bias, and that the 
FACIT scale was developed for those in active treatment, not cancer survivors (Swen, 
Mann, Paxton, & Dean, 2017). 
Numerical Severity Screening 
In 2014, ASCO published clinical practice guidelines on the screening, 
assessment, and management of fatigue in cancer survivors. The guideline was informed 
by existing guidelines from the pan-Canadian guideline which was formed from 
recommendations from the ONS and the NCCN (Bower, et al., 2014). ASCO 
recommends screening all patients at least annually for CRF, more frequently if 
43 
 
indicated. Screening is done using a numerical severity scale, 0 being no fatigue and 10 
being worst fatigue in the last week (Bower, et al., 2014). Patients who score 4-10 on the 
screening should then be further evaluated using a multisymptom tool. Included in the 
guideline is a table listing the potential instruments for evaluating fatigue (Bower, et al., 
2014). The available unidimensional scales include FACT-F and POMS and the 
multidimensional scales include BFI, FSI, MFSI-20 and 30, and the Revised PFS (Bower, 
et al., 2014). Other scales mentioned in the guideline but not covered in this review 
include the Schwartz Cancer Fatigue Scale, the Chalder Fatigue Scale, and the European 
Organization for Research and Treatment of Cancer, Quality of Life Questionnaire 
(EORTC-QLQ). The guideline goes on to detail the comprehensive physical assessment 
along with potential interventions (Bower, et al., 2014). 
In 2018, the NCCN issued updated survivorship guidelines with a section on 
CRF. This guideline is similar to the ASCO guideline and recommends screening for 
fatigue in every cancer survivor at least annually and as clinically indicated (NCCN, 
2018). Screening is done using a numerical severity scale with 0 being no fatigue and 10 
being worst fatigue over the previous week. Those that score 4-10 indicating moderate to 
severe fatigue are then further evaluated with a comprehensive history and physical. 
NCCN does not make a recommendation regarding the best assessment tool nor do they 
list available assessment instruments (NCCN, 2018). 
Analysis 
The articles in the literature review are all examples of fatigue assessment tools 
being used in the survivorship population. Most studies were cross-sectional analyses (7), 
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with 1 mixed method-randomized controlled trial, and 1 each of cohort study, feasibility 
study, descriptive study, and prospective observational study. The most commonly used 
assessment tools include the FACIT used 3 times, CFS-D used twice, PFS used twice, 
and the BFI also used twice. The MFSI-SF and the FACT-B were each used once. 
Finally, 1 study used 3 assessment tools: SF-36, FSI, and POMS-Fatigue. (See Appendix 
B) 
The data analysis was conducted using the GRADE approach which consists of 5 
basic steps. (See Table 1) First is to set a priori ranking based on the type of study 
according to the hierarchy of evidence. (See figure 1) For example, a randomized 
controlled trial is ranked high and an observational study would be ranked low. Second 
step is to either upgrade or downgrade this priori ranking according to certain criteria. For 
example, risk of bias would indicate a downgrade while a large consistent effect of 
outcome could justify an upgrade. Third is to assign the final GRADE, either high, 
moderate, low, or very low. Fourth is to take into consideration other factors such as cost-
effectiveness and patient preference. Finally, is to make a recommendation either strong 
for using, weak for using, strong against using, or weak against using (Siemieniuk & 
Guyatt, 2018). 
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Table 1 
 
GRADE Process 
Step 1: 
A prior 
ranking 
 
Step 2: 
Upgrade/downgrade 
 
Step 3: 
GRADE 
assignment 
Step 4: 
Consider factors 
affecting 
recommendation 
Step 5: 
Make 
recommendation 
Randomized 
controlled 
trial: HIGH 
 
Observational 
study: LOW 
Downgrade for: 
Risk of bias 
Inconsistency 
Indirectness 
Imprecision 
Publication bias 
 
Upgrade for: 
Large consistent 
effect 
Dose response 
Confounders only 
Reducing size of 
effect 
HIGH 
 
MODERATE 
 
LOW 
 
VERY LOW 
Balance of 
desirable and 
undesirable 
effects 
 
Cost-
effectiveness 
 
Preference of 
patients 
Strong for Using 
 
Weak for using 
 
Strong against 
using 
 
Weak against 
using 
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Higher           Lower 
 
 
Quality of         Risk of Bias 
Evidence 
 
 
Lower           Higher 
Figure 1. Hierarchy of evidence pyramid. 
 
 
GRADE was applied to the 14 sources in the literature review matrix. Of these, I 
assigned 4 an initially high ranking, 9 a moderate ranking, and 1 a low ranking. After 
taking into consideration bias and limitations of each source the final GRADE consisted 
of 2 high, 3 moderate, 8 low, and 1 very low. I considered other factors such as cost-
effectiveness, time efficiency, and ease of use for patients, reliability and validity of 
scale, and multidimensional or single dimensions. Of the 14 sources, 2 are recommended 
as strong for using, 6 are recommended as weak for using, and 6 are recommended as 
weak against using. None are considered strong against using (see Table 2). 
 
Systematic Reviews and 
Meta-analyses of RCTs 
Randomized Controlled Trials 
Cohort Studies 
Case-Controlled Studies 
Cross-Sectional Studies; Surveys 
Case Reports; Case Studies 
Mechanistic Studies 
Editorials; Expert Opinion 
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Table 2  
 
GRADE Summary of Findings 
Author(s), 
year 
Rankinga Up/downgrade GRADE Other factors Recommendation Fatigue 
tool 
NCCN, 
2018 
High None High Cost and time 
effective. 
Ease of 
screening for 
patients. 
Strong for using Numerical 
screening 
Bower et 
al., 2014 
High None High Cost and time 
effective. 
Ease of 
screening for 
patients. 
Strong for using Numerical 
screening 
Kroz et al., 
2017 
High Down-bias 
and 
limitationsb 
Mod Reliable scale 
and valid 
measures of 
multiple 
dimensions. 
Weak for using CFS-D 
Stan et al., 
2016 
Mod Down-study 
limitationsb 
Low Reliable and 
valid fatigue 
scale. 
Weak for using MFSI-SF 
Galiano-
Castillo et 
al., 2014 
Mod Down-study 
limitationsb 
Low Fatigue scale 
with high 
reliability. 
Weak for using Revised 
PFS 
Goedendorp 
et al., 2016 
Mod Down-study 
limitationsb 
Low Efficient 
screening. 
SF-36 has 
reverse 
worded 
items. 
Weak against 
using 
SF-36; 
FSI; 
POMS-
fatigue 
Swen et al., 
2017 
Mod Down-bias 
and 
limitationsb 
Low None. Weak against 
using 
FACIT 
Hall et al., 
2014 
Mod Down-study 
limitationsb 
Low Validated 
fatigue scale 
for multiple 
domains of 
fatigue. 
Weak for using Revised 
PFS 
Jones et al., 
2016 
Mod None Low Scale 
supported by 
Weak for using FACIT 
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psychometric 
data. 
Mao et al., 
2018 
Mod Down-bias 
and 
limitationsb 
Low Internal 
consistency 
of fatigue 
scale. 
Weak against 
using 
BFI 
Lev-ari et 
al., 2013 
Mod Down-study 
limitationsb 
Low None. Weak against 
using 
FACIT 
Kroz et al., 
2014 
Low Down-bias 
and 
limitationsb 
Very 
low 
Fatigue scale 
with good 
reliability, 
validity, and 
test-retest 
reliability. 
Weak against 
using 
CFS-D 
Smith et al., 
2013 
High Down-study 
limitationsb 
Mod Fatigue scale 
with good 
sensitivity to 
change over 
time. 
Weak for using BFI 
Kaur et al., 
2018 
Mod Down-study 
limitationsb 
Low None. Weak against 
using 
FACT-B 
Note. a Initial ranking is either high, moderate, low, or very low. b See literature review 
table for study limitations. 
 
The 2 sources considered strong for using with a high final GRADE include the 
NCCN and ASCO guidelines. Both of these guidelines recommend initial screening of all 
breast cancer survivors using a numerical severity scale with 4 being the cutoff to 
indicated potentially clinically significant fatigue. Then further assessment using any 
fatigue measurement instrument (Bower et al., 2014; NCCN, 2018). The fatigue 
assessment tools used in the sources that received a weak for using recommendation 
include the CFS-D, MFSI-SF, PFS, FACIT, and the BFI. PFS was recommended twice as 
weak for using. The fatigue assessment tools using in the sources that received a weak 
against using include the SF-36, FSI, POMS-fatigue, FACIT, BFI, FACIT, CFS-D, and 
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FACT-b. The only assessment tool that received a ‘for using’ recommendation and did 
not receive an ‘against using’ recommendation was the PFS. 
An unanticipated outcome was the lack of current articles addressing this topic. 
Other than the 2 clinical practice guidelines, all of the other sources were research using 
fatigue assessment scales in breast cancer survivors, but none of the sources evaluated 
which scale was the most appropriate to use. This limits their applicability to the question 
at hand and limits the conclusions that can be drawn from the sources. Another 
unanticipated outcome is that the 2 clinical practice guidelines made no recommendation 
as to which fatigue assessment scale to use when more thorough and detailed assessment 
is warranted. Leaving the decision up to the individual practitioner. 
There are a few implications to address. On the individual level, the assessment of 
fatigue can lead to a more accurate clinical picture of the situation and thus more targeted 
interventions. For the community of breast cancer survivors, addressing fatigue in a 
targeted purposeful way could help reduce the number of patient suffering from CRF and 
improve the QOL for this population. For the institution, and health system as a whole, 
improved QOL and less distressing symptoms for breast cancer survivors could mean a 
decrease over-utilization of the health care system. Relieving the burden of CRF from 
individual patients, the local breast cancer survivor population, and the university health 
system. All of these potential implications can contribute to positive social change. 
Recommendations 
The results of this literature review support the use of the NCCN or ASCO 
guidelines in the screening of fatigue. However, the review does not provide enough 
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evidence to clearly support any specific follow up tool in the assessment of potentially 
clinically significant cases of fatigue. Screening of all survivors at initial survivorship 
visit and periodically thereafter using a numerical severity scale from 0-10 with 0 being 
none and 10 being severe fatigue. This can be done during rooming for office visits, 
similar to how the pain scale is used. If the score is 4 or greater then further evaluation is 
warranted. Further evaluation can then be done with one the various tools described in 
this review. See Appendix C for a summary of the tools. 
Implementation would begin with education of the clinicians and nurses providing 
survivorship care. Education would include background on the clinical problem, 
necessity of screening and assessment, and education on use of the screening tool. Next 
would be incorporating the screening into the electronic health record and into clinic 
flow. Then, an important step to implementation is to receive feedback from patients and 
staff and make adjustments in the process as necessary. 
Strengths and Limitations of the Project 
Strengths of the doctoral project include logical flow through the data collection, 
practical organization of data, and use of a specific criteria for analyzing the data. 
Another strength is the availability of high quality evidence in the form of 2 clinical 
practice guidelines that address this topic. Conversely, the majority of sources discovered 
in the literature review were cross-sectional studies which is of low priori ranking in 
GRADE. Again, one of the limitations was the lack of sources that specifically addressed 
the question, limiting their applicability to the question. Another limitation is the lack of 
panel of reviewers applying the GRADE criteria. Panel consensus is stronger and more 
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objective with different viewpoints coming to a decision together than an individual’s 
viewpoint which can be subjective. 
It is clear that more research needs to done on this topic. The various fatigue 
scales and assessment tools need to be evaluated under more rigorous conditions to 
reduce the bias and limitations found in this review and result in more reliable results. 
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Section 5: Dissemination Plan 
Dissemination 
A few avenues exist for potential dissemination of my findings to the institution 
and to the broader nursing profession. The information and conclusions from the 
systematic review could be presented via PowerPoint or poster to the breast cancer care 
team during the weekly breast team meetings. For the wider institution, dissemination 
could be done through the weekly cancer institute grand rounds forum. For the statewide 
cancer community, the information could be presented to the ACC through a poster at 
their annual meeting. For national oncology nursing profession, the systematic review 
could be submitted for publication through the ONS or APSHO. 
Analysis of Self 
I began this journey toward the DNP in January of 2016. I then began my career 
in oncology in September of 2016. At that time, my mentor, being ever supportive of my 
education and growth as a practitioner, presented a survivorship clinical problem: fatigue 
interfering with sexual function in breast cancer survivors. My mentor then challenged 
me to investigate this problem and I was not sure where to even begin. The journey 
through this program has guided me in the pursuit of this clinical problem and has 
prepared me to take on future problems as a scholar practitioner. My next goal is to 
achieve certification in oncology advanced practice. Long-term professional goals would 
be to grow the survivorship clinic to include other cancer survivors, such as melanoma 
and colon, and to be able to provide a truly multidisciplinary clinic. 
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This project was a daunting task. It involves many steps and pages of writing to 
fully cover the scope of the issue and to thoroughly address the gap in practice. I certainly 
experienced frustrations and delays throughout the quarters. Personal issues interfered 
and then my own disorganization and procrastination interfered. Thankfully, my 
committee chair was ever present to help me focus my premise, revise and fine tune my 
proposal, and complete my data collection and analysis. Ultimately, I was prepared to 
synthesis the data results and present my findings along with recommendations for 
clinical practice and for future research. The process, although daunting at first, evolved 
in an organic way. 
Summary 
This doctoral project is a culmination of doctoral study. It is a systematic review 
of the literature, the purpose of which is to address a gap in nursing practice. The guiding 
clinical practice question was: What is the best method of assessing CRF in breast cancer 
survivors? The literature review and analysis revealed that no recommended assessment 
tool exists in this population but rather suggestions of several different fatigue 
measurement tools. The most robust evidence was for the use of the NCCN and ASCO 
guidelines that recommend screening using a numerical severity scale and then further 
assessing those patients who score 4 or greater. The further assessment can be done using 
several different instruments and this review does not support the use of any 1 tool. 
54 
 
References 
American Society of Clinical Oncology. (2018). Quality oncology practice initiative. 
Retrieved from https://practice.asco.org/quality-improvement/quality-
programs/quality-oncology-practice-initiative  
American Society of Clinical Oncology. (n.d.). Survivorship compendium. Retrieved 
from https://www.asco.org/practice-guidelines/cancer-care-initiatives/prevention-
survivorship/survivorship/survivorship-compendium 
Alonso-Coello, P., Oxman, A. D., Moberg, J., Brignardello-Petersen, R., Akl, E. A., 
Davoli, M., . . . Verstijnen, I. (2016). GRADE Evidence to Decision (EtD) 
frameworks: A systematic and transparent approach to making well informed 
healthcare choices. 2: Clinical practice guidelines. British Medical Journal, 353, 
i2089. doi:10.1136/bmj.i2089 
Appling, S. E., Scarvalone, S., MacDonald, R., McBeth, M., & Helzlsouer, K. J. (2012). 
Fatigue in breast cancer survivors: The impact of a mind-body medicine 
intervention. Oncology Nursing Forum, 39, 278–286. doi:10.1188/12.ONF.278-
286 
Arkansas Cancer Coalition. (2015). Arkansas cancer plan: Cancer is personal. Retrieved 
from http://www.arcancercoalition.org/wp-content/uploads/2010 
/09/508_ACC_CancerPlan_Final_MINI_REV.pdf 
Arkansas Department of Health. (2017). Arkansas Cancer Facts & Figures 2017. 
Retrieved from https://www.healthy.arkansas.gov/images/uploads/ 
publications/ARCancerFacts2017.pdf 
55 
 
Bower, J. E., Bak, K., Berger, A., Breitbart, W., Escalante, C. P., Ganz, P. A., . . 
Jacobsen, P. B. (2014). Screening, assessment, and management of fatigue in 
adult survivors of cancer: An American Society of Clinical Oncology clinical 
practice guideline adaptation. Journal of Clinical Oncology, 32, 1840–1850. 
doi:10.1200/JCO.2013.53.4495 
Breastcancer.org. (n.d.). U.S. breast cancer statistics. Retrieved from 
https://www.breastcancer.org/symptoms/understand_bc/statistics 
Cella, D., Webster, K., Cella, D., & Yost, K. (2003). Functional assessment of chronic 
illness therapy measurement system. Health and Quality of Life Outcomes, 1, 1–7. 
doi:10.1186/1477-7525-1-79 
Centers for Disease Control and Prevention. (2004). A national action plan for cancer 
survivorship: Advancing public health strategies. Centers for Disease Control and 
Prevention. Retrieved from https://www.cdc.gov/cancer/survivors/pdf/plan.pdf 
Cheung, S. Y., & Delfabbro, P. (2016). Are you a cancer survivor? A review on cancer 
identity. Journal of Cancer Survivorship, 10, 759–771. doi:10.1007/s11764-016-
0521-z 
Clark, K. R., & Buckley, M. B. (2017). Using a synthesis matrix to plan a literature 
review. Radiologic Technology, 88, 354–358. Retrieved from 
http://www.radiologictechnology.org/content/88/3/354.full.pdf+html 
Corbett, T., Groarke, A. M., Walsh, J. C., & McGuire, B. E. (2016). Cancer-related 
fatigue in post-treatment cancer survivors: Application of the common sense 
model of illness representations. BMC Cancer, 16, 919. doi:10.1186/s12885-016-
56 
 
2907-8 
Doyle, N. (2008). Cancer survivorship: Evolutionary concept analysis. Journal of 
Advanced Nursing, 62, 499–509. doi:10.1111/j.1365-2648.2008.04617.x 
Dyess, S. M. (2011). Faith: A concept analysis. Journal of Advanced Nursing, 67, 723–
731. doi:10.1111/j.1365-2648.2011.05734.x 
Endo, E. (2017). Margaret Newman’s theory of health as expanding consciousness and a 
nursing intervention from a unitary perspective. Asia-Pacific Journal of Oncology 
Nursing, 4, 50–52. doi:10.4103/2347/5625.199076 
Endo, E., Miyahara, T., Suzuki, S., & Ohmasa, T. (2005). Partnering of researcher and 
practicing nurses for transformative nursing. Nursing Science Quarterly, 18, 138–
145. doi:10.1177/0894318405274845.  
Fabi, A., Falcicchio, C., Giannarelli, D., Maggi, G., Cognetti, F., & Pugliese, P. (2017). 
The course of cancer related fatigue up to ten years in early breast cancer patients: 
What impact in clinical practice? Breast, 34, 44–52. 
doi:10.1016/j.breast.2017.04.012 
Galiano-Castillo, N., Ariza-Garcia, A., Cantarero-Villanueva, I., Fernandez-Lao, C., 
Diaz-Rodriguez, L., & Arroyo-Morales, M. (2014). Depressed mood in breast 
cancer survivors: Associations with physical activity, cancer-related fatigue, 
quality of life, and fitness level. European Journal of Oncology Nursing, 18, 206–
210. doi:10.1016/j.ejon.2013.10.008 
Goedendorp, M. M., Jacobsen, P. B., & Andrykowski, M. A. (2016). Fatigue screening in 
breast cancer patients: Identifying likely cases of cancer-related fatigue. Psycho-
57 
 
Oncology, 25, 275–281. doi:10.1002/pon.3907 
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & 
Schünemann, H. J. (2008). GRADE: An emerging consensus on rating quality of 
evidence and strength of recommendations. British Medical Journal, 9, 8–11. 
doi:10.1136/bmj.39489.470347.AD 
Hall, D. L., Mishel, M. H., & Germino, B. B. (2014). Living with cancer-related 
uncertainty: Associations with fatigue, insomnia, and affect in younger breast 
cancer survivors. Supportive Care in Cancer, 22, 2489–2495. 
doi:10.1007/s00520-014-2243-y 
Hann, D. M., Jacobsen, P. B., Azzarello, L. M., Martin, S. C., Curran, S. L., Fields, K, . . 
. Lyman, G. (1998). Measurement of fatigue in cancer patients: development and 
validation of the fatigue symptom inventory. Quality of Life Research, 7, 301-
310. Retrieved from https://link.springer.com/article/10.1023/A:1024929829627 
Hebdon, M., Foli, K., & McComb, S. (2015). Survivor in the cancer context: A concept 
analysis. Journal of Advanced Nursing, 71, 1774–1786. doi:10.1111/jan.12646 
Huether, K., Abbott, L., Cullen, L., Cullen, L., & Gaarde, A. (2016). Energy through 
motion: An evidence-based exercise program to reduce cancer-related fatigue and 
improve quality of life. Clinical Journal of Oncology Nursing, 20, E60-E70. 
doi:10.1188/16.CJON.E60-E70 
Hewitt, M., Greenfield, S., & Stovall, E. (2005). From Cancer Patient to Cancer 
Survivor. From Cancer Patient to Cancer Survivor. National Academies Press. 
doi:10.17226/11468 
58 
 
Hofman, M., Ryan, J. L., Figueroa-Moseley, C. D., Jean-Pierre, P., & Morrow, G. R. 
(2007). Cancer-related fatigue: The scale of the problem. The Oncologist, 
12(suppl 1), 4–10. doi:10.1634/theoncologist.12-S1-4 
James, S., Wright, P., Scarlett, C., Young, T., Jamal, H., & Verma, R. (2015). Cancer-
related fatigue: results from patient experience surveys undertaken in a UK 
regional cancer centre. Supportive Care in Cancer, 23, 2089–2095. 
doi:10.1007/s00520-014-2565-9 
Jones, J. M., Olson, K., Catton, P., Catton, C. N., Fleshner, N. E., Krzyzanowska, M. K., . 
. . Howell, D. (2016). Cancer-related fatigue and associated disability in post-
treatment cancer survivors. Journal of Cancer Survivorship, 10(1), 51–61. 
doi:10.1007/s11764-015-0450-2 
Kantor, D., & Suzan, Z. (2016). Issues of Cancer Survivorship: An Interdisciplinary 
Team Approach to Care. Philadelphia, PA: Wolters Kluwer. 
Kaur, N., Gupta, A., Sharma, A. K., & Jain, A. (2018). Survivorship issues as 
determinants of quality of life after breast cancer treatment: Report from a limited 
resource setting. Breast, 41, 120–126. doi:10.1016/j.breast.2018.07.003 
Kröz, M., Reif, M., Bartsch, C., Heckmann, C., Zerm, R., Schad, F., & Girke, M. (2014). 
Impact of autonomic and self-regulation on cancer-related fatigue and distress in 
breast cancer patients - a prospective observational study. Journal of Cancer 
Survivorship, 8, 319–328. doi:10.1007/s11764-013-0314-6 
Kröz, M., Reif, M., Glinz, A., Berger, B., Nikolaou, A., Zerm, R., . . . Gutenbrunner, C. 
(2017). Impact of a combined multimodal-aerobic and multimodal intervention 
59 
 
compared to standard aerobic treatment in breast cancer survivors with chronic 
cancer-related fatigue - results of a three-armed pragmatic trial in a 
comprehensive cohort design. BMC Cancer, 17(1), 1–14. doi:10.1186/s12885-
017-3142-7 
Lev-ari, S., Zilcha-Mano, S., Rivo, L., Geva, R., & Ron, I. (2013). A prospective pilot 
clinical trial of “The work” meditation technique for survivors of breast cancer. 
European Journal of Integrative Medicine, 5, 487–494. 
doi:10.1016/j.eujim.2013.07.003 
Makhoul, I., Pennisi, A., Ochoa, D., Klimberg, S., Henry-Tillman, R., Hutchins, L., & 
Sherman, A. (2014). Assessment of quality of life outcomes among breast cancer 
patients and their partners after primary treatment (unpublished protocol). 
University of Arkansas for Medical Sciences. Little Rock, AR 
Mao, H., Bao, T., Shen, X., Li, Q., Seluzicki, C., Im, E. O., & Mao, J. J. (2018). 
Prevalence and risk factors for fatigue among breast cancer survivors on 
aromatase inhibitors. European Journal of Cancer, 101, 47–54. 
doi:10.1016/j.ejca.2018.06.009 
Mast, M. (1998). Correlates of fatigue in survivors of breast cancer. Cancer Nursing. 21, 
136–142. Retrieved from https://journals.lww.com 
/cancernursingonline/pages/default.aspx 
Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. 
K., & Huber, S. L. (1998). The rapid assessment of fatigue severity in cancer 
patients: Use of the brief fatigue inventory. Cancer, 85, 1186–1196. 
60 
 
doi:10.1002/(SICI)1097-0142  
Miller, L. E. (2014). Uncertainty management and information seeking in cancer 
Survivorship. Health Communication, 29, 233–243. 
doi:10.1080/10410236.2012.739949 
Mishel, M. H. (1990). Reconceptualization of the uncertainty in illness theory. Journal of 
Nursing Scholarship, 22, 256–262. doi:10.1111/j.1547-5069.1990.tb00225.x 
Mitchell, S. A. (2015). Fatigue. In C. G. Brown (Ed.), A Guide to Oncology Symptom 
Management (2nd ed., p. 22). Pittsburgh, PA: Oncology Nursing Society. 
Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., . . . 
Whitlock, E. (2015). Preferred reporting items for systematic review and meta-
analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews, 4(1), 1–9. 
doi:10.1186/2046-4053-4-1. 
National Cancer Institute. (n.d.). NCI-Designated Cancer Centers. Retrieved from 
https://www.cancer.gov/research/nci-role/cancer-centers 
NCCN. (2018). Survivorship. NCCN Clinical Practice Guidelines in Oncology. 
Retrieved from https://www.nccn.org/professionals 
/physician_gls/pdf/survivorship.pdf 
Neville, K. L. (2003). Uncertainty in illness: An integrative review. Orthopaedic 
Nursing, 22, 206–214. Retrieved from 
https://journals.lww.com/orthopaedicnursing/toc/2003/05000 
Noonan, K. (2016). Pain, Fatigue, and Cognitive Impairment. In W. H. Gobel, B. H., 
Triest-Robertson, S., Vogel (Ed.), Advanced Oncology Nursing Certification: 
61 
 
Review and resource manual (2nd ed., p. 44). Pittsburgh, PA: Oncology Nursing 
Society. 
Okuyama, T., Akechi, T., Kugaya, A., Okamura, H., Shima, Y., Maruguchi, M., . . . 
Uchitomi, Y. (2000). Development and validation of the cancer fatigue scale: A 
brief, three-dimensional, self-rating scale for assessment of fatigue in cancer 
patients. Journal of Pain and Symptom Management, 19, 5–
14. doi:10.1016/S0885-3924(99)00138-4 
Pannucci, C. J., Wilkins, E. G. (2010). Identifying and avoiding bias in research. Plastic 
and Reconstructive Surgery, 126, 619–625. 
doi:10.1097/PRS.0b013e3181de24bc.Identifying 
Petiprin, A. (2016). Health as expanding consciousness. Retrieved from 
http://www.nursing-theory.org/theories-and-models/newman-health-as-
expanding-consciousness 
Piper, B. F., Dibble, S. L., Dodd, M. J., Weiss, M. C., Slaughter, R. E., & Paul, S. M. 
(1998). The revised piper fatigue scale: psychometric evaluation in women with 
breast cancer. Oncology Nursing Forum. 25, 677-684. Retrieved from UAMS 
interlibrary loan. 
RAND Corporation. (n.d.). RAND Medical Outcomes Study: Measure of Quality of Life 
Core Survey from RAND Health Care. Retrieved from 
https://www.rand.org/health-care/surveys_tools/mos.html  
Ream, E., & Richardson, A. (1996). Fatigue: A concept analysis. International Journal of 
Nursing Studies, 33, 519–529. doi:10.1016/0020-7489(96)00004-1 
62 
 
Reeve, B. B., Stover, A. M., Alfano, C. M., Smith, A. W., Ballard-Barbash, R., Bernstein, 
L., . . . Piper, B. F. (2012). The piper fatigue scale-12 (PFS-12): Psychometric 
findings and item reduction in a cohort of breast cancer survivors. Breast Cancer 
Research and Treatment, 136, 9–20. doi:10.1007/s10549-012-2212-4 
Ryan, J. L., Carroll, J. K., Ryan, E. P., Mustian, K. M., Fiscella, K., & Morrow, G. R. 
(2007). Mechanisms of cancer-related fatigue. The Oncologist, 12(suppl 1). 22-
34. doi:10.1634/theoncologist12-s1-22 
Sacham, S. (1983). A shortened version of the profile of mood states. Journal of 
Personality Assessment, 47, 305-306. doi:10.1207/s15327752jpa4703_14.  
Shapiro, C. L., Jacobsen, P. B., Henderson, T., Hurria, A., Nekhlyudov, L., Ng, A., . . . 
Rowland, J. H. (2016). ReCAP: ASCO core curriculum for cancer survivorship 
education. Journal of Oncology Practice, 12, 145–145. 
doi:10.1200/JOP.2015.009449 
Siemieniuk, R., Guyatt, G. (2018). What is GRADE? Retrieved from 
https://bestpractice.bmj.com/info/us/toolkit/learn-ebm/what-is-grade/ 
Smith, C., Carmady, B., Thornton, C., Perz, J., & Ussher, J. M. (2013). The effect of 
acupuncture on post-cancer fatigue and well-being for women recovering from 
breast cancer: A pilot randomised controlled trial. Acupuncture in Medicine, 
31(1), 9–15. doi:10.1136/acupmed-2012-010228 
Smith, M. C. (2011). Integrative review of research related to Margaret Newman’s theory 
of health as expanding consciousness. Nursing Science Quarterly, 24, 256–272. 
doi:10.1177/0894318411409421 
63 
 
Spielberger, C. D. (1972). Review of profile of mood states. Professional Psychology, 
3(4), 387–388. doi:10.1037/h0020742 
Stan, D. L., Croghan, K. A., Croghan, I. T., Jenkins, S. M., Sutherland, S. J., Cheville, A. 
L., & Pruthi, S. (2016). Randomized pilot trial of yoga versus strengthening 
exercises in breast cancer survivors with cancer-related fatigue. Supportive Care 
in Cancer, 24, 4005–4015. doi:10.1007/s00520-016-3233-z 
Stein, K. D., Jacobsen, B., Blanchard, C. M., & Thors, C. (2004). Further validation of 
the multidimensional fatigue symptom inventory-short form. Journal of Pain and 
Symptom Management, 27, 14-23. doi:10.1016/j.jpainsymman.2003.06.003  
Swen, M., Mann, A., Paxton, R. J., & Dean, L. T. (2017). Do cancer-related fatigue and 
physical activity vary by age for black women with a history of breast cancer? 
Preventing Chronic Disease, 14, E122. doi:10.5888/pcd14.170128 
Terry, A. J. (2015). Clinical Research for the Doctor of Nursing Practice (2nd ed.). 
Burlington, MA: Jones & Bartlett Learning. 
Tramm, R., McCarthy, A., & Yates, P. (2012). Using the precede-proceed model of 
health program planning in breast cancer nursing research. Journal of Advanced 
Nursing, 68, 1870–1880. doi:10.1111/j.1365-2648.2011.05888.x 
Twombly, R. (2004). What’s in a name: Who is a cancer survivor?. Journal of the 
National Cancer Institute, 96, 1414-1415. doi:10.1093/jnci/96.19.1414.  
Walden University. (2017a). 2017-2018 Walden University Catalog. Walden Univeristy. 
Retrieved from http://catalog.waldenu.edu/mime 
/media/149/4598/Sept_Cat_2017.pdf 
64 
 
Walden University. (2017b). Manual for systematic reviews Doctor of Nursing Practice 
Scholarly Project. Walden University. Retrieved from 
https://academicguides.waldenu.edu/ld.php?content_id=32773133 
Wang, X. S., & Woodruff, J. F. (2015). Cancer-related and treatment-related fatigue. 
Gynecologic Oncology, 136, 446–452. doi:10.1016/j.ygyno.2014.10.013 
Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey 
(SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473-483. 
Retrieved from https://pdfs.semanticscholar.org/06cb 
/0076e310136d0ca8b56cc8585ec2bf43e029.pdf 
Weis, J. (2011). Cancer-related fatigue : prevalence, assessment and treatment strategies. 
Expert Review Pharmacoeconomics Outcomes Research, 11, 441–446. 
doi:10.1586/ERP.11.44 
Wonghongkul, T., Dechaprom, N., Phumivichuvate, L., & Losawatkul, S. (2006). 
Uncertainty appraisal coping and quality of life in breast cancer survivors. Cancer 
Nursing, 29, 250–257. doi:10.1097/00002820-200605000-00014 
Wonghongkul, T., Moore, S. M., Musil, C., Schneider, S., & Deimling, G. (2000). The 
influence of uncertainty in illness, stress appraisal, and hope on coping in 
survivors of breast cancer. Cancer Nursing, 23, 22–429. doi:10.1097/00002820-
200012000-00004 
Yellen, S. B., Cella, D. F., Webster, K., Blendowski, C., & Kaplan, E. (1997). Measuring 
fatigue and other anemia-related symptoms with the Functional Assessment of 
Cancer Therapy (FACT) measurement system. Journal of Pain and Symptom 
65 
 
Management, 13, 63–74. doi:10.1016/s0885-3924(96)00274-6 
  
66 
 
Appendix A: PRISMA 
PRISMA Flow Diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed100009 
  
Records identified through 
database searching  
(n =17) 
S
cr
e
e
n
in
g
 
In
cl
u
d
e
d
 
E
li
g
ib
il
it
y
 
Id
e
n
ti
fi
ca
ti
o
n
 
Additional records identified 
through other sources  
(n =7) 
ONS, ASCO, NCCN, Cochrane 
Records after duplicates removed  
(n = 23) 
Records screened  
(n = 23) 
Records excluded  
(n = 9) 
Full-text articles 
assessed for eligibility  
(n = 14) 
Full-text articles 
excluded  
(n =0) 
Studies included in 
qualitative synthesis  
(n =14) 
67 
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women 
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Swen et 
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Black Women 
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period of 7 
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reduces recall 
bias. 
Conducted 
during the 
summer 
months to 
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Analyzed by 
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whole. 
does not establish a 
causal relationship 
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and emotional 
fatigue. Use of self-
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Facit scale 
developed for those 
in active cancer 
treatment, not 
surviviors. 
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al/2014 
Living with 
cancer-related 
uncertainty: 
associations 
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affect in 
younger breast 
cancer 
survivors 
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sectional 
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relationship 
between cancer-
related uncertainty 
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persistent concern 
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significantly related 
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well-validated 
scale that 
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multiple 
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fatigue. More 
diverse sample 
with both 
african 
american and 
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does not establish a 
causal relationship. 
Self-report measures 
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insomnia, better to 
use objective 
measures. 
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Jones 
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associated 
disability in 
post-treatment 
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survivors 
FACT-F Cross-
sectional 
Assess the 
prevalence of CRF 
across time in 
breast, prostate, 
and colorectal 
cancer survivors. 
Found mean 
fatigue scores were 
higher in breast 
and colorectal 
groups but did not 
differ by time. CRF 
persists upt to 6 
years post-primary 
treatment. 
FACT-F 
correlates with 
ICD and NCCN 
definitions of 
CRF. 
Psychometric 
data to support 
its use. Large 
sample size 
from three 
prominent 
cancer groups, 
high response 
rate. 
cross-sectional 
design only assess 
CRF at one-time. 
Can not draw causal 
conclusions. 
Mao et 
al/2018 
Prevalence 
and risk factors 
for fatigue 
among breast 
cancer 
survivors on 
aromatase 
inhibitors 
BFI Cross-
sectional 
Define prevalence 
of fatigue in 
survivors on 
aromatase 
inhibitors (AI), 
along with risk 
factors for fatigue 
and relationship 
with comorbid 
symptoms. 4 in 5 
AI users 
experience fagiute 
with more than 1 in 
2 having moderate 
to severe fatigue. 
brief fatigue 
insturment. 
large sample 
size. Focus on 
specific group 
of fatigue 
sufferers 
self-report can lead 
to recall bias, study 
of survivors on AI 
only not of survivors 
with no AI, can not 
establish causal 
relationship. BFI is 
not 
multidimensional. 
Lev-ari 
et 
al/2013 
A prospective 
pilot clinicl trial 
of "The work" 
meditation 
technique for 
survivors of 
breast cancer 
FACT Descripti
ve study 
of pilot 
program 
Pilot program to 
evaluate the 
feasibilty and 
effectivness of 
meditation in 
improving well 
being in breast 
cancer survivors. 
Found significant 
improvement in 
physical and 
mental health after 
intervention. 
high level of 
compliance and 
no adverse 
effects reproted 
lack of control group, 
modest sample size, 
self-selection, 
reliance of self-
report outcomes, no 
data over time 
Kroz et 
al/2014 
Impact of 
autonomic and 
self-regulation 
on cancer-
related fatigue 
and distress in 
breast cancer 
patients- a 
prospective 
observational 
study 
CFS-D Prospecti
ve 
observati
onal 
Study of autonomic 
regulation and self-
regulation as 
predictors of CRF, 
cognitive fatigue, 
and distress. High 
autonomic 
regulation co-
occurs with 
reduced risk of 
CRF. High self-
regulation 
associated with 
reduced symptoms 
of distress 
looks at 
cognitive 
fatigue in 
addition to 
phsycial 
fatigue. Use of 
reliable 
estimate of 
CRF 
small cohort, 
observational study 
not causation, 
selection bias, 
caucasian sample, 
patient-related 
outcome measures 
should be confirmed 
with phsyciological 
measures 
Smith et 
al/2013 
The effect of 
acupuncture 
on post-cancer 
fatigue and 
well-being for 
women 
recovering 
from breast 
BFI Mixed 
method 
RCT 
Feasibility of 
acupuncture in 
management of 
fatigue and well-
being in breast 
cancer survivors. 
Concluded the 
Good treatment 
compliance and 
BFI sensitive to 
changes in 
farigue during 
the intervention 
as supported 
by qualitative 
slow recruitement. 
Small number in pilot 
study, short 
duration, dose 
response bias 
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cancer: a pilot 
randomised 
controlled trial 
intervention was 
acceptable. 
interviews. 
Randomization 
with control 
group. No 
issues with 
needles and 
devices as in 
previous 
studies. 
Kaur et 
al/2018 
Survivorship 
issues as 
determinants 
of quality of life 
after breast 
cancer 
treatment: 
Report from a 
limited 
resource 
setting 
FACT-B Cross-
Sectional 
To understand the 
perspective of 
indian BC survivors 
and their QOL 
limitations. Most 
commonly reported 
issues include 
fatigue, shoulder 
restriction, body 
and joint pain, 
chemotherapy 
induced cessation 
of menstration, and 
loss of sexual 
desire. 
Control group 
of age-matched 
healthy women. 
First studty to 
look at this 
population. 
hospital based study 
so does not reflect 
issues in ambulatory 
setting. Cross-
sectional not 
longitudinal. 
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Appendix C: Summary of Tools 
Tool Uni or 
Multidimensional 
Number of 
items 
Type of report Subscales or domains measured 
POMS Uni 37 self-report Tension-anxiety; depression-dejection; anger-hostility; 
fatigue-inertia; vigor-activity; confusion-bewilderment 
SF-36 Multi 36 Self-report or 
clinician 
administered 
physical functioning, role limitations because of 
physical health problems, bodily pain, social 
functioning, and mental health, roll limitations because 
of emotional problems, vitality, and general health 
perceptions 
FACT Uni 47 Self-report physical well-being, social/family well-being, 
relationship with physician, emotional well-being, and 
functional well-being 
PFS Multi 12 Self-report behavior/severity, affective meaning, sensory, and 
cognitive/mood 
BFI Uni 9 Self-report how the fatigue interferes with general activity, mood, 
walking ability, normal work, relationships, and 
enjoyment of life 
FSI Multi-Multi 7 Self-report or 
clinician 
administered 
the amount of interference the fatigue had on general 
activity, activities of daily living, work, concentration, 
relationships, enjoyment, and mood 
MFSI-SF Multi 30 Self-report General fatigue, physical fatigue, emotional fatigue, 
mental fatigue, and vigor. 
CFS Multi 15 Self-report physical, affective, and cognitive dimensions 
FACIT Multi 13 Self-report or 
clinician 
administered 
physical well-being, social/family well-being, emotional 
well-being, and functional well-being 
 
